Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis

BACKGROUND: Epicardial adipose tissue (EAT) plays an important role in cardiometabolic risk. EAT is a modifiable risk factor and could be a potential therapeutic target for drugs that already show cardiovascular benefits. The aim of this study is to evaluate the effect of cardiometabolic drugs on EA...

Descripción completa

Detalles Bibliográficos
Autores principales: Myasoedova, Veronika A., Parisi, Valentina, Moschetta, Donato, Valerio, Vincenza, Conte, Maddalena, Massaiu, Ilaria, Bozzi, Michele, Celeste, Fabrizio, Leosco, Dario, Iaccarino, Guido, Genovese, Stefano, Poggio, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890718/
https://www.ncbi.nlm.nih.gov/pubmed/36721184
http://dx.doi.org/10.1186/s12933-023-01738-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890718/
https://www.ncbi.nlm.nih.gov/pubmed/36721184
http://dx.doi.org/10.1186/s12933-023-01738-2

Ejemplares similares